BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30623363)

  • 1. Targeting Colon Cancers with Mutated BRAF and Microsatellite Instability.
    Matos P; Jordan P
    Adv Exp Med Biol; 2018; 1110():7-21. PubMed ID: 30623363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
    Minoo P; Moyer MP; Jass JR
    J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
    Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.
    Lin CC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Jiang JK; Yang MH; Chang SC
    J Surg Oncol; 2014 Sep; 110(4):451-7. PubMed ID: 24964758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.
    Chouhan H; Sammour T; L Thomas M; W Moore J
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):69-74. PubMed ID: 30421554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
    Cohen R; Cervera P; Svrcek M; Pellat A; Dreyer C; de Gramont A; André T
    Curr Treat Options Oncol; 2017 Feb; 18(2):9. PubMed ID: 28214977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
    Cohen R; Svrcek M; Dreyer C; Cervera P; Duval A; Pocard M; Fléjou JF; de Gramont A; André T
    Curr Oncol Rep; 2016 Mar; 18(3):18. PubMed ID: 26861657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.
    Panarelli NC; Vaughn CP; Samowitz WS; Yantiss RK
    Am J Surg Pathol; 2015 Mar; 39(3):313-7. PubMed ID: 25602793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the serrated pathway of colorectal cancer with mutation in BRAF.
    Matos P; Gonçalves V; Jordan P
    Biochim Biophys Acta; 2016 Aug; 1866(1):51-63. PubMed ID: 27345584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of BRAF V600E Mutations in High-Level Microsatellite Instability(MSI-H)Colon Cancer - Comparison Between Genetic Testing and Immunohistochemical Staining].
    Sakimoto T; Chika N; Suzuki O; Ishibashi K; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1693-1695. PubMed ID: 28133101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML
    J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
    Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
    Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.
    Birgisson H; Edlund K; Wallin U; Påhlman L; Kultima HG; Mayrhofer M; Micke P; Isaksson A; Botling J; Glimelius B; Sundström M
    BMC Cancer; 2015 Mar; 15():125. PubMed ID: 25884297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.
    Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors.
    Cárcano FM; Lengert AH; Vidal DO; Scapulatempo Neto C; Queiroz L; Marques H; Baltazar F; Berardinelli GN; Martinelli CM; da Silva EC; Reis RM; Lopes LF
    Andrology; 2016 Sep; 4(5):866-72. PubMed ID: 27153176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.